{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:54:28Z","timestamp":1783090468399,"version":"3.54.6"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1990,4]]},"DOI":"10.1212\/wnl.40.4.707","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T12:55:53Z","timestamp":1336913753000},"page":"707-707","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Blood pressure and plasma catecholamines in never\u2010treated parkinsonian patients"],"prefix":"10.1212","volume":"40","author":[{"given":"G.","family":"Durrieu","sequence":"first","affiliation":[{"name":"Laboratoire de Pharmacologie Me\u0301dicale et Clinique (INSERM U317) (Mrs. Durrieu and Drs. Senard, O. Rascol, Tran, and Montastruc), and the Service de Neurologie (Pr. A Rascol), Centre Hospitalier Universitaire et Faculte\u0301 de Me\u0301decine, Toulouse, France, and Sandoz Laboratories (Dr. Lataste), Basel, Switzerland. G. Durrieu is a fellow of the Association \u201cFrance-Parkinson.\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Senard","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Me\u0301dicale et Clinique (INSERM U317) (Mrs. Durrieu and Drs. Senard, O. Rascol, Tran, and Montastruc), and the Service de Neurologie (Pr. A Rascol), Centre Hospitalier Universitaire et Faculte\u0301 de Me\u0301decine, Toulouse, France, and Sandoz Laboratories (Dr. Lataste), Basel, Switzerland. G. Durrieu is a fellow of the Association \u201cFrance-Parkinson.\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Rascol","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Me\u0301dicale et Clinique (INSERM U317) (Mrs. Durrieu and Drs. Senard, O. Rascol, Tran, and Montastruc), and the Service de Neurologie (Pr. A Rascol), Centre Hospitalier Universitaire et Faculte\u0301 de Me\u0301decine, Toulouse, France, and Sandoz Laboratories (Dr. Lataste), Basel, Switzerland. G. Durrieu is a fellow of the Association \u201cFrance-Parkinson.\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Tran","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Me\u0301dicale et Clinique (INSERM U317) (Mrs. Durrieu and Drs. Senard, O. Rascol, Tran, and Montastruc), and the Service de Neurologie (Pr. A Rascol), Centre Hospitalier Universitaire et Faculte\u0301 de Me\u0301decine, Toulouse, France, and Sandoz Laboratories (Dr. Lataste), Basel, Switzerland. G. Durrieu is a fellow of the Association \u201cFrance-Parkinson.\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Lataste","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Me\u0301dicale et Clinique (INSERM U317) (Mrs. Durrieu and Drs. Senard, O. Rascol, Tran, and Montastruc), and the Service de Neurologie (Pr. A Rascol), Centre Hospitalier Universitaire et Faculte\u0301 de Me\u0301decine, Toulouse, France, and Sandoz Laboratories (Dr. Lataste), Basel, Switzerland. G. Durrieu is a fellow of the Association \u201cFrance-Parkinson.\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rascol","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Me\u0301dicale et Clinique (INSERM U317) (Mrs. Durrieu and Drs. Senard, O. Rascol, Tran, and Montastruc), and the Service de Neurologie (Pr. A Rascol), Centre Hospitalier Universitaire et Faculte\u0301 de Me\u0301decine, Toulouse, France, and Sandoz Laboratories (Dr. Lataste), Basel, Switzerland. G. Durrieu is a fellow of the Association \u201cFrance-Parkinson.\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Montastruc","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Me\u0301dicale et Clinique (INSERM U317) (Mrs. Durrieu and Drs. Senard, O. Rascol, Tran, and Montastruc), and the Service de Neurologie (Pr. A Rascol), Centre Hospitalier Universitaire et Faculte\u0301 de Me\u0301decine, Toulouse, France, and Sandoz Laboratories (Dr. Lataste), Basel, Switzerland. G. Durrieu is a fellow of the Association \u201cFrance-Parkinson.\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.40.4.707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:18:22Z","timestamp":1711552702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.40.4.707"}},"subtitle":["Effect of a selective D\n            <sub>1<\/sub>\n            agonist (CY 208\u2010243)"],"short-title":[],"issued":{"date-parts":[[1990,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,4]]}},"alternative-id":["10.1212\/WNL.40.4.707"],"URL":"https:\/\/doi.org\/10.1212\/wnl.40.4.707","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,4]]}}}